Arcturus Therapeutics Holdings Inc (ARCT)
17.82
-0.18
(-1.00%)
USD |
NASDAQ |
Nov 04, 16:00
17.83
+0.01
(+0.06%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Profit Margin (Quarterly): -37.45% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -37.45% |
| March 31, 2024 | -82.27% |
| December 31, 2023 | -46.68% |
| September 30, 2023 | -37.40% |
| June 30, 2023 | -549.4% |
| March 31, 2023 | 63.66% |
| December 31, 2022 | 73.32% |
| September 30, 2022 | -263.8% |
| June 30, 2022 | -79.59% |
| March 31, 2022 | -975.8% |
| December 31, 2021 | -667.3% |
| September 30, 2021 | -2.22K% |
| June 30, 2021 | -2.73K% |
| March 31, 2021 | -2.65K% |
| December 31, 2020 | -1.39K% |
| September 30, 2020 | -900.3% |
| Date | Value |
|---|---|
| June 30, 2020 | -442.0% |
| March 31, 2020 | -369.5% |
| December 31, 2019 | -370.2% |
| September 30, 2019 | -224.0% |
| June 30, 2019 | -6.75% |
| March 31, 2019 | -158.3% |
| December 31, 2018 | -13.34% |
| September 30, 2018 | -124.2% |
| June 30, 2018 | -417.0% |
| March 31, 2018 | -277.6% |
| December 31, 2017 | -261.4% |
| September 30, 2017 | -96.39% |
| June 30, 2017 | -29.22% |
| March 31, 2017 | |
| December 31, 2016 | 83.92% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.73K%
Minimum
Jun 2021
73.32%
Maximum
Dec 2022
-719.5%
Average
-370.2%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | 69.26% |
| Bioventus Inc | -15.87% |
| Semler Scientific Inc | 0.08% |
| Liquidia Corp | -763.7% |
| Pfizer Inc | 25.22% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -26.33% |
| Return on Assets | -16.93% |
| Return on Invested Capital | -25.95% |
| Operating Margin (Quarterly) | -45.95% |
| Return on Net Operating Assets | -108.5% |